CEMTREX INC (CETX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CETX • US15130G8731

1.52 USD
-0.03 (-1.94%)
Last: Feb 11, 2026, 10:55 AM
Fundamental Rating

2

CETX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 123 industry peers in the Electronic Equipment, Instruments & Components industry. CETX may be in some trouble as it scores bad on both profitability and health. CETX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CETX had negative earnings in the past year.
  • In the past year CETX had a positive cash flow from operations.
  • In the past 5 years CETX always reported negative net income.
  • CETX had negative operating cash flow in 4 of the past 5 years.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • CETX's Return On Assets of -59.34% is on the low side compared to the rest of the industry. CETX is outperformed by 82.93% of its industry peers.
  • Looking at the Return On Equity, with a value of -325.30%, CETX is doing worse than 91.87% of the companies in the same industry.
  • With a Return On Invested Capital value of 1.69%, CETX perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
Industry RankSector Rank
ROA -59.34%
ROE -325.3%
ROIC 1.69%
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • CETX has a Operating Margin (0.67%) which is comparable to the rest of the industry.
  • CETX has a better Gross Margin (42.21%) than 72.36% of its industry peers.
  • CETX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.67%
PM (TTM) N/A
GM 42.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1

2. Health

2.1 Basic Checks

  • CETX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CETX has more shares outstanding
  • The number of shares outstanding for CETX has been increased compared to 5 years ago.
  • Compared to 1 year ago, CETX has an improved debt to assets ratio.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • CETX has an Altman-Z score of -1.13. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.13, CETX is doing worse than 74.80% of the companies in the same industry.
  • CETX has a Debt/Equity ratio of 0.53. This is a neutral value indicating CETX is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.53, CETX is doing worse than 70.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Altman-Z -1.13
ROIC/WACC0.34
WACC4.92%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • CETX has a Current Ratio of 1.22. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.22, CETX is not doing good in the industry: 82.93% of the companies in the same industry are doing better.
  • CETX has a Quick Ratio of 1.22. This is a bad value and indicates that CETX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CETX has a Quick ratio of 0.94. This is amonst the worse of the industry: CETX underperforms 80.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.94
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.65% over the past year.
  • CETX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.39%.
  • The Revenue has been growing by 11.95% on average over the past years. This is quite good.
EPS 1Y (TTM)97.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.62%
Revenue 1Y (TTM)14.39%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%2.16%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 2M -2M 4M -4M -6M

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 0.74, the valuation of CETX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CETX is valued cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CETX to the average of the S&P500 Index (27.97), we can say CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.74
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CETX is valued cheaper than 95.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.89
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 -200

4.3 Compensation for Growth

  • CETX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CEMTREX INC

NASDAQ:CETX (2/11/2026, 10:55:08 AM)

1.52

-0.03 (-1.94%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)12-29
Earnings (Next)02-12
Inst Owners0.36%
Inst Owner Change8555.43%
Ins Owners0%
Ins Owner Change0%
Market Cap1.12M
Revenue(TTM)76.49M
Net Income(TTM)-28.36M
Analysts82.86
Price TargetN/A
Short Float %99.03%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.74
P/S 0.01
P/FCF N/A
P/OCF 7.06
P/B 0.13
P/tB 0.29
EV/EBITDA 6.89
EPS(TTM)-241.29
EYN/A
EPS(NY)2.05
Fwd EY134.88%
FCF(TTM)-3.74
FCFYN/A
OCF(TTM)0.22
OCFY14.16%
SpS103.36
BVpS11.78
TBVpS5.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.34%
ROE -325.3%
ROCE 2.13%
ROIC 1.69%
ROICexc 2.13%
ROICexgc 2.86%
OM 0.67%
PM (TTM) N/A
GM 42.21%
FCFM N/A
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Debt/EBITDA 2.46
Cap/Depr 216.16%
Cap/Sales 3.83%
Interest Coverage 0.5
Cash Conversion 8.53%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.94
Altman-Z -1.13
F-Score5
WACC4.92%
ROIC/WACC0.34
Cap/Depr(3y)194.3%
Cap/Depr(5y)152.34%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.62%
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.39%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%2.16%
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.03%
OCF growth 3YN/A
OCF growth 5YN/A

CEMTREX INC / CETX FAQ

Can you provide the ChartMill fundamental rating for CEMTREX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CETX.


Can you provide the valuation status for CEMTREX INC?

ChartMill assigns a valuation rating of 4 / 10 to CEMTREX INC (CETX). This can be considered as Fairly Valued.


Can you provide the profitability details for CEMTREX INC?

CEMTREX INC (CETX) has a profitability rating of 2 / 10.


How financially healthy is CEMTREX INC?

The financial health rating of CEMTREX INC (CETX) is 1 / 10.


Can you provide the expected EPS growth for CETX stock?

The Earnings per Share (EPS) of CEMTREX INC (CETX) is expected to grow by 265.45% in the next year.